US09076G2030 - ADR
BIOPHYTIS SA-ADR
NASDAQ:BPTS (4/18/2024, 7:00:02 PM)
After market: 0.3 -0.03 (-7.98%)0.326
+0.04 (+12.26%)
Biophytis SA operates as a clinical-stage biotechnology company. The company is headquartered in Paris, Ile-De-France and currently employs 26 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
BIOPHYTIS SA-ADR
14 avenue de l'Opera
Paris ILE-DE-FRANCE 75252
P: 33141836600
CEO: Stanislas Veillet
Employees: 26
Website: https://www.biophytis.com/
On Wednesday, there are stocks with unusual volume. Let's take a look.
Curious about the stocks that are showing activity before the opening bell on Wednesday?
Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today!
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.
Get insights into the top gainers and losers of Tuesday's pre-market session.
Here you can normally see the latest stock twits on BPTS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: